We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+16.98%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$295B
AUM Growth
+$35.4B
Cap. Flow
-$1.58B
Cap. Flow %
-0.53%
Top 10 Hldgs %
22.42%
Holding
3,425
New
145
Increased
1,798
Reduced
1,253
Closed
125

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$1B
2
AAPL icon
Apple
AAPL
+$797M
3
MRK icon
Merck
MRK
+$316M
4
AMZN icon
Amazon
AMZN
+$308M
5
MDT icon
Medtronic
MDT
+$298M

Sector Composition

Rank Sector Weight
1 Technology 24.73%
2 Healthcare 13.29%
3 Consumer Discretionary 13.23%
4 Financials 12.2%
5 Communication Services 9.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WTRG icon
1176
Essential Utilities
WTRG
$11.4B
$22.5M 0.01%
476,262
-183,901
-28% -$8.17M
EPRT icon
1177
Essential Properties Realty Trust
EPRT
$6.62B
$22.5M 0.01%
1,062,156
-306,989
-22% -$6.01M
ROG icon
1178
Rogers Corp
ROG
$2.4B
$22.5M 0.01%
145,003
+14,317
+11% +$1.9M
SGMO
1179
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$22.5M 0.01%
1,440,260
+73,749
+5% +$864K
LEG icon
1180
Leggett & Platt
LEG
$1.31B
$22.4M 0.01%
506,765
+50,733
+11% +$2.18M
PPBI
1181
DELISTED
Pacific Premier Bancorp
PPBI
$22.4M 0.01%
714,789
+39,693
+6% +$1.1M
FLIR
1182
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
$22.3M 0.01%
509,679
-93,230
-15% -$3.6M
TAK icon
1183
Takeda Pharmaceutical
TAK
$55.7B
$22.3M 0.01%
+1,225,317
New +$21.5M
SPXC icon
1184
SPX Corp
SPXC
$10.8B
$22.3M 0.01%
408,770
-30,434
-7% -$1.53M
BWXT icon
1185
BWX Technologies
BWXT
$15.6B
$22.3M 0.01%
369,656
+30,472
+9% +$1.76M
CVLT icon
1186
Commault Systems
CVLT
$5.61B
$22.3M 0.01%
402,359
-104,263
-21% -$4.87M
APG icon
1187
APi Group
APG
$18B
$22M 0.01%
1,815,914
+764,124
+73% +$8.09M
CDLX icon
1188
Cardlytics
CDLX
$21.5M
$22M 0.01%
15,385
+2,407
+19% +$2.57M
MODV
1189
DELISTED
ModivCare
MODV
$21.8M 0.01%
157,346
+11,024
+8% +$1.37M
BNL icon
1190
Broadstone Net Lease
BNL
$4.02B
$21.8M 0.01%
1,113,696
+237,047
+27% +$4.19M
BBWI icon
1191
Bath & Body Works
BBWI
$4.1B
$21.8M 0.01%
725,122
+1,972
+0.3% +$57.2K
FLG
1192
Flagstar Bank National Association
FLG
$5.82B
$21.8M 0.01%
688,692
-1,609
-0.2% -$44.4K
MEDP icon
1193
Medpace
MEDP
$16.5B
$21.8M 0.01%
156,580
+66
+0% +$8.32K
GTN icon
1194
Gray Television
GTN
$552M
$21.7M 0.01%
1,215,285
+652,053
+116% +$10.3M
PACB icon
1195
Pacific Biosciences
PACB
$370M
$21.7M 0.01%
837,852
+175,450
+26% +$2.98M
TRTN
1196
DELISTED
Triton International Limited
TRTN
$21.7M 0.01%
446,666
+101,693
+29% +$4.3M
PNR icon
1197
Pentair
PNR
$11B
$21.6M 0.01%
407,499
+28,630
+8% +$1.47M
PAC icon
1198
Grupo Aeroportuario del Pacifico
PAC
$13.3B
$21.6M 0.01%
194,059
+3,558
+2% +$352K
ACA icon
1199
Arcosa
ACA
$7.11B
$21.5M 0.01%
391,867
+63,456
+19% +$3.24M
SMTC icon
1200
Semtech
SMTC
$13B
$21.5M 0.01%
298,359
-18,898
-6% -$1.21M

Similar funds

Nuveen's Q4 2020 Portfolio in Review

As of Q4 2020, Nuveen held 3,425 positions worth $295B, up 14% from $260B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Nuveen's Q4 2020 filing shows 145 new, 1,798 increased, 1,253 reduced and 125 closed positions. Its largest new stake was iShares Core MSCI EAFE ETF: 3,133,484 shares worth $216M. The largest sale was Walt Disney, an estimated $587M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Nuveen's largest Q4 2020 buy was iShares Core MSCI EAFE ETF: 3,133,484 shares worth $216M.
  • Nuveen added most to Microsoft in Q4 2020, an estimated $1B increase.
  • Nuveen's biggest Q4 2020 reduction was Walt Disney, cutting an estimated $587M.
  • Nuveen fully exited Alcon in Q4 2020, selling an estimated $174M.
  • Nuveen's ten largest holdings make up 22% of its $295B portfolio in Q4 2020.
  • Nuveen opened 145 new positions and closed 125 in Q4 2020.
  • Nuveen's portfolio value rose 14% quarter-over-quarter to $295B.

Based on Nuveen's 13F filing for Q4 2020, filed 16 Feb 2021.